As of 2026-09-13, the Relative Valuation of Atea Pharmaceuticals Inc (AVIR) is (53.39) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.31 USD, the upside of Atea Pharmaceuticals Inc based on Relative Valuation is -1105.4%.
The range of the Relative Valuation is (35.69) - (44.98) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 35.3x | 30.4x |
| Forward P/E multiples | 16.6x - 21.8x | 21.3x |
| Fair Price | (35.69) - (44.98) | (53.39) |
| Upside | -772.1% - -947.1% | -1105.4% |
| Date | P/E |
| 2026-09-10 | -2.51 |
| 2026-09-09 | -2.55 |
| 2026-09-08 | -2.75 |
| 2026-09-04 | -2.82 |
| 2026-09-03 | -2.82 |
| 2026-09-02 | -2.76 |
| 2026-09-01 | -2.66 |
| 2026-08-31 | -2.59 |
| 2026-08-28 | -2.60 |
| 2026-08-27 | -2.64 |
| 2026-08-26 | -2.67 |
| 2026-08-25 | -2.63 |
| 2026-08-24 | -2.67 |
| 2026-08-21 | -2.63 |
| 2026-08-20 | -2.60 |
| 2026-08-19 | -2.71 |
| 2026-08-18 | -2.56 |
| 2026-08-17 | -2.53 |
| 2026-08-14 | -2.48 |
| 2026-08-13 | -2.45 |
| 2026-08-12 | -2.45 |
| 2026-08-11 | -2.45 |
| 2026-08-10 | -2.43 |
| 2026-08-07 | -2.54 |
| 2026-08-06 | -2.42 |
| 2026-08-05 | -2.30 |
| 2026-08-04 | -2.28 |
| 2026-08-03 | -2.23 |
| 2026-07-31 | -2.28 |
| 2026-07-30 | -2.30 |
| 2026-07-29 | -2.24 |
| 2026-07-28 | -2.18 |
| 2026-07-27 | -2.33 |
| 2026-07-24 | -2.29 |
| 2026-07-23 | -2.30 |
| 2026-07-22 | -2.33 |
| 2026-07-21 | -2.36 |
| 2026-07-20 | -2.31 |
| 2026-07-17 | -2.36 |
| 2026-07-16 | -2.28 |
| 2026-07-15 | -2.35 |
| 2026-07-14 | -2.28 |
| 2026-07-13 | -2.30 |
| 2026-07-10 | -2.42 |
| 2026-07-09 | -2.38 |
| 2026-07-08 | -2.33 |
| 2026-07-07 | -2.36 |
| 2026-07-06 | -2.36 |
| 2026-07-02 | -2.41 |
| 2026-07-01 | -2.31 |